30th ADLM International CPOCT Symposium

Building resilience through point-of-care innovations

DoubleTree Pittsburgh
One Bigelow Square
Pittsburgh, PA 15219
October 14–16, 2026

Planning Committee

Anna Fuezery, PhD, DABCC, CPP (Chair)
Alberta Precision Laboratories
Edmonton, AB, Canada

Nicholas Larkey, PhD, DABCC, NRCC, CPP, FADLM
University of Virginia
Charlottesville, VA, USA

Jeanne Mumford, MLS(ASCP)
Johns Hopkins Hospital
Baltimore, MD, USA

Nam Tran, PhD, HCLD (ABB), FADLM
University of Pittsburgh, School of Medicine
Pittsburgh, PA, USA

Wanvisa Treebuphachatsakul, PhD
Naresuan University
Muang, Phitsanulok, Thailand

Faculty

• Mickayla Karikari, MHA, MLS(ASCP)CM, CPP | Johns Hopkins Community Physicians
• Jason Kearns, MBA | University of Pittsburgh Medical Center
• Gerald J. Kost, MD, PhD, MS, FADLM | University of California, Davis
• Wilbur Lam, MD, PhD | Emory University
• Robert D. Maynard, PhD, DABCC, NRCC | University of Kentucky
• Steve Miller, MD, PhD | Delve Bio
• John Moon | Former Freedom House Paramedic and Retired Assistant Chief of Pittsburgh EMS
• Samantha Tinsay, MD, MBA | Cebu Doctors University College of Medicine

Target audience

This symposium is designed to meet the needs of laboratory professionals overseeing and/or carrying out point-of-care testing, clinical laboratory physicians, supervisors, managers, regulatory personnel, and other laboratory professionals interested in advances in point-of-care testing.

Learning objectives

Learning objectives coming soon.

Disclosures and statement of independence

The Association for Diagnostics & Laboratory Medicine (formerly AACC) is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments. Faculty disclosures of relevant financial relationship(s) will be provided in respective presentations and program materials.

The following planners and faculty reported relevant financial relationship(s):

• Anna Fuezery
  • Honorarium: Roche, Abbott
  • Salary: Alberta Precision Laboratories
• Jeanne Mumford
  • Honorarium: Cepheid Speaker Bureau, Next Generation Dx Summit
  • Advisory Board/Committee Membership: BioMerieux
• Nam Tran
  • Honorarium: Roche Diagnostics, Nova Biomedical, Werfen
  • Consultant Fees: Roche Diagnostics, Radiomter
  • Ownership: MILO-ML, Inc
• Robert D. Maynard
  • Consultant Fee: Werfen, Sebia
• Steve Miller
  • Stocks and/or Bonds: Delve Bio
  • Salary: Delve Bio
  • Intellectual Property/Royalty Income: Patents related to metagenomic testing

The following planners and faculty reported no relevant financial relationship(s):

• Nicholas Larkey
• Wanvisa Treebuphachatsakul
• Mickayla Karikari
• Jason Kearns
• Gerald J. Kost
• John Moon
• Samantha Tinsay

All staff involved in the planning of this activity reported no financial relationships.

Content validity

All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; AND/OR all scientific research referred to or reported in support or justification of a patient care recommendation that conforms to generally accepted standards of experimental design, data collection, and analysis.

Acknowledgement of sponsorship

This activity is sponsored by: BioMérieux, Siemens Healthineers, and Radiometer.

Accreditation statement

This educational activity will be submitted for 10.75 ACCENT continuing education credits.